Post on 14-Apr-2018
7/27/2019 HCC 2013 SOTA Treatment
1/54
M@@Fb tml Xlst> @urrlbt PEYO trlotklbt
Seclrt H. Hfsm KI
Plbfer Klif`oj Ifrl`ter, Pt NeslpmsKlif`oj @lbtlr Wmelbfx
@jfbf`oj Wredlsser ed Klif`fbl
\bfvlrsfty ed Blvoio
7/27/2019 HCC 2013 SOTA Treatment
2/54
Tf`tfks ed M@@
Nemobbls Cromks
Soy @morjls
iftm Wfod
http://en.wikipedia.org/wiki/File:%C3%89dith_Piaf.jpghttp://en.wikipedia.org/wiki/File:Ray_Charles_(cropped).jpghttp://en.wikipedia.org/wiki/File:JohannesBrahms.jpg7/27/2019 HCC 2013 SOTA Treatment
3/54
\PO Yml Xlst
7/27/2019 HCC 2013 SOTA Treatment
4/54
Mlpote`ljjujor @or`fbeko Ojherftmk Keifdfli drek> Cor`ljebo @jfbf` Jfvlr @ob`lr
(C@J@) - Jjevlt NK lt oj. N Botj @ob`lr Fbst. 377=1?77>46=-8??
Ptohl 7WPY 7,
@mfji-Yur`ettl-Wuhm O
Ptohl O-@WPY 7-3,
@mfji-Yur`ettl-Wuhm O er C Ptohl I
WPY 23,@mfji-Yur`ettl-Wuhm @
Tlry lorjy stohl (7)Pfbhjl :3 `k
`or`fbeko fb sftu
Lorjy stohl (O)Pfbhjl beiujl :< `ker 0 beiujls 0 `k,
WPY 7
Iewbstohl Crfihl
Oivob`li stohl (@)Wertoj fbvosfeb,
B?, K?, WPY ?-3Ylrkfbojstohl (I)
Pfbhjl 0 beiujls 0 `k
Fb`rlosli pertojprlssurl obi ljlvotli
cfjfrucfb jlvljsVls
Osse`fotliifslosls
Be VlsBe
Slsl`tfeb
Jfvlr trobspjobtotfeb
(@JY er JIJY) SDO (WLFo)
Ocjotfeb (PCSY,
SD, YOCL2
YOSL,YO@L)
: 0 tukers
: < `k
YOL er YO@LJe`oj @mlke- er Soife-
tmlropy
(@mlke er Cloi
lkcejfzotfeb,
Soifelkcejfzotfeb)
Perodlbfc@mlke
Puppertfvl @orl
Purvfvoj :0 kebtms
Klifob survfvoj ??-37 kebtms
YOSL,
YOCL, PCSY
serodlbfc5c
*@ekcfbotfebs,
PCSY, YOSL,
YOCL5c
oSorljy usli. c@ebdfrkotfeb rlqufrli drek S@Ys.
PCSY ; Ptlrleto`tf` Ceiy Soifotfeb Ymlropy
Fbtlrklifotl stohl (C)Kujtfbeiujor, WPY 7
Pojvohl
Pojvohl
7/27/2019 HCC 2013 SOTA Treatment
5/54
JF-SOIP
Koss5Be
JS0
Ecslrvotfeb
Clbfhb lbtfty5
JS? JS3
Wrecocjl
Ildfbftl
Yuker fb vlfb5
Vls
Vls
Blftmlr ildfbftl berprecocjl
Oppjy Ob`fjjory Dloturls obi tmlb Yfl-Crloafbh Sujls te Oinust @otlhery
JS
@opsujl
v37?0.?
@otlherfls FbilxKobohlklbt Yl`mbfqulSlpertfbhEvlrvflwFbtre
O`abewjlihklbts
Oinust@otlhery
Evlrvflw>
JF-SOIP `otlherfzlsecslrvotfebsrldjl`tfbh
jfaljfmeei ed clbfhbfty er M@@ fb ot-rfsa
potflbts, os smewb fb ojherftmk.
Ildfbftljy er precocjy clbfhb ecslrvotfebs orl
`otlherfzli JS?obi JS3, rlspl`tfvljy.
Slkofbfbh ecslrvotfebs tmot orl bet kossls
tmlb orl otlherfzli JS0.Kossls wftm dloturls suhhlstfvl ed beb-M@@
kojfhbob`yorl `otlherfzli Etmlr Kojfhbob`y
(EK).
Slkofbfbh kossls wftm ildfbftl tuker fb vlfb
orl otlherfzli JS
7/27/2019 HCC 2013 SOTA Treatment
6/54
Yeyeio M, lt oj. @jfb Hostrelbtlrej Mlpotej. 377419>???-8.
Purvlfjjob`l der Mlpote`ljjujor @or`fbekoCfekoralrs> ODW, ODW-J0 obi I@W
Wottlrb ed cfekoralrs fb potflbts wftm M@@
7/27/2019 HCC 2013 SOTA Treatment
7/54
M@@ Cfekoralr Woblj
OJWJ0% obi I@W
\sls obi \tfjfzotfeb Mfhmlr jlvljs osse`fotli wftm
Tos`ujor fbvosfeb
Kerl peerjy ifddlrlbtfotli tukers
Mfhmlr rfsa ed rl`urrlb`l odtlr surhlry obitrobspjobt
Blor tlrk prlif`ter ed ilvljepfbh M@@ fd betuker fs prlslbt eb fkohfbh
7/27/2019 HCC 2013 SOTA Treatment
8/54
Yrlotklbt der M@@
Slsl`tfeb
Yrobspjobtotfeb
Fkohl-hufili fbtlrvlbtfebs WLF
SDO, KwO
@mlkelkcejfzotfeb, YOCL, YOSL
47 87%
V67, I@ Clois
6-?= Kebtms
klifob survfvoj
Yorhltli tmlropfls 0 kebtms iljtoklifob survfvoj
7/27/2019 HCC 2013 SOTA Treatment
9/54
Yrlotklbt
Ebjy oceut 07% ed potflbts wme prlslbtot kest `lbtlrs movl lorjy-stohlifslosl.
87% `obifiotl der `ekpesftl trlotklbt,er fbvlstfhotfeboj er systlkf` tmlropy
@ob`lr trlotklbt fb mfstery @ut
Curb
Wefseb
7/27/2019 HCC 2013 SOTA Treatment
10/54
Purhf`oj Slsl`tfeb
Lxpl`totfebs ed rlsl`tfeb> :0% eplrotfvl kertojfty :?7% trobsdusfeb rlqufrlklbt + LT,pjotljlts : ?77,777 kk0 er spjlbeklhojy
Sl`urrlb`l> 47%-87%fbtromlpotf`, 07%-97% il beve M@@
LT> lsepmohloj vorf`ls.
?. Faof F lt oj. @ob`lr.37791?7?>864-=73. 3. Toutmly NB lt oj. N @jfb Eb`.37731 37>?
7/27/2019 HCC 2013 SOTA Treatment
11/54
Yml cfhhlst il`fsfeb>Slsl`tfeb vs Yrobspjobtotfeb
@lbtlr Lxplrflb`l
@ujturoj Ottftuils
Wro`tf`l Wottlrbs
Slsl`tfeb Yrobspjobtot feb
Wre @ebBe woftfbh tfkl
7/27/2019 HCC 2013 SOTA Treatment
12/54
Soifedrlqulb`y Ocjotfeb (SDO)
Soifedrlqulb`y tmlrkoj lblrhy oppjfli te tmltuker
Der potflbts wme ie bet kllt rlsl`tfeb`rftlrfo obi orl @mfji-Wuhm O er C
Clst der tukers jlss tmob 9`kIfokltlr (`k) @ekpjltl je`oj `ebtrej
:3.< 67%
3.
7/27/2019 HCC 2013 SOTA Treatment
13/54
Jlb`febf lt oj.> 374 potflbts wftm lorjy-stohl ubrlsl`tocjlM@@ trlotli wftm SDO?
Ptohl 0-yr
Purvfvoj
7/27/2019 HCC 2013 SOTA Treatment
14/54
Mebh lt oj.> ?9= potflbts @mfji O1 `osl`ebtrej SDO vs surhf`oj rlsl`tfeb?
Fs SDO Clttlr Ymob Purhf`oj Slsl`tfeb5
Ymlropy ?-yr Purvfvoj 0-yr Purvfvoj Sl`urrlb`l
Purhlry
(B ; 60)68% =6% 9
7/27/2019 HCC 2013 SOTA Treatment
15/54
SDO
@ebtrofbif`otfebs
@mfjis @ potflbts ( 38% vs 4.< - =%)
@jesl prexfkfty ( :?`k) Cfjliu`ts
Cjeei vlssljs
\PL KF@SEXOTL erLJL@YSEWESOYFEB
Jorhl tukers ( 2
7/27/2019 HCC 2013 SOTA Treatment
16/54
Blw Ymlrkoj Yl`mbfqul>Kf`rewovl Ocjotfeb
Mfhmlr fbtrotukeroj tlkplroturls
Fkprevli `ebvl`tfeb predfjl
Cfhhlr ocjotfeb vejukls Dostlr ocjotfeb tfkls
Jlss pofb
Be mlot-sfba lddl`t Blli kerl fbderkotfeb rlhorifbh
lddf`o`y `ekporli te SDO
7/27/2019 HCC 2013 SOTA Treatment
17/54
Ljl`terperotfeb
Bevlj Ocjotfeb Yl`mbfqul Koy Clbldft Wotflbts Xftm
Kojfhbobt Jfvlr Jlsfebs.
Klis`opl(9/34/37?9, Morrfseb) rlperts, "O bevlj ocjotfebtl`mbfqul tmot iels bet rljy eb mlot er `eji fs o sodl obi
dlosfcjl woy te torhlt kojfhbobt jfvlr jlsfebs tmot orl ifddf`ujt teocjotl cl`ousl ed tmlfr prexfkfty te koner ortlrfls obi vlfbs,o``erifbh te blw rlslor`m" prlslbtli ot tml Oklrf`obSelbthlb Soy Pe`flty 37?0 Obbuoj Klltfbh. Slslor`mlrs"usli plr`utobleus frrlvlrsfcjl ljl`treperotfeb te trlot 3= jfvlrtukers bet suftocjl der `ebvlbtfeboj tmlropy er je`otli fb oborlo bet oklbocjl der roifedrlqulb`y ocjotfeb." Ymlrlslor`mlrs deubi tmot "`ekpjltl ocjotfeb ed vfocjl tuker tfssulwos o`mflvli fb 3? tukers."
http://mailview.bulletinhealthcare.com/mailview.aspx?m=2013042601aga&r=5110936-7d65&l=002-6db&t=chttp://mailview.bulletinhealthcare.com/mailview.aspx?m=2013042601aga&r=5110936-7d65&l=002-6db&t=c7/27/2019 HCC 2013 SOTA Treatment
18/54
Fbtro-ortlrfoj Je`erlhfeboj Ymlropy
YO@L Xftm jfpfeiej
YOSLSoifelkcejfzotfeb> yttrfuk-67roifeo`tfvl kf`respmlrls
YOCLIruh-ljutfbh clois (J@ Clois)
7/27/2019 HCC 2013 SOTA Treatment
19/54
Jorhlst Wrespl`tfvl Ptuiy ed YO@L der
\brlsl`tocjl M@@ te Iotl
B ; = =3%1 Vlor 0> 98%1 Vlor 34%1 Vlor 8> ?4%
EP clttlr wftm jlsslr ilhrll ed jfvlr iokohl
Do`ters oddl`tfbh survfvoj @mfji-Wuhm stohl YBK stohl (EP clttlr wftm stohl F, fb`rlosfbhjy wersl prehrlssfbh
tewori stohl FT)
Ojpmo-dltepretlfb jlvlj
Yoaoyosu A, lt oj. Hostrelbtlrejehy. 37741?0?>94?-946.
7/27/2019 HCC 2013 SOTA Treatment
20/54
YO@L> @mlkelkcejfzotfeb>
Lddf`o`y Clderl Yrobspjobtotfeb
Koner fssul> irepeut rotl (oreubi 37%) Jlss fb tml \P sfb`l oieptfeb ed KLJI `rftlrfo Sejl ed YO@L
@ebtrej tuker hrewtm + prlvlbt prehrlssfeb
Pmeuji cl `ebsfilrli fd woftfbh tfkl 24 kebtms @ekpjf`otfebs drek YO@L rorl (be fb`rlosli rotl
ed mlpotf` ortlry `ekpjf`otfebs) YO@L usli os prlif`ter ed tuker cfejehy fb
potflbts owoftfbh trobspjobtotfeb Purvfvoj + tuker-drll survfvoj> rlspebilrs te YO@Lku`m hrlotlr clbldft tmob beb-rlspebilrs
Sf`mori MK 0ri lt oj. Soifejehy. 377713?9(0)>88
7/27/2019 HCC 2013 SOTA Treatment
21/54
@mlkelkcejfzotfeb> Fbljfhfcfjfty@rftlrfo
Ocsejutl `ebtrofbif`otfebs
@mfji @
Weer plrderkob`l stotus (L@EH 23)Sljotfvl `ebtrofbif`otfebs
Lxtromlpotf` ifslosl (5 Clbldft)
Wertoj vlfb tmrekcesfs5 BE JEBHLS!(Kfbfkfzl lkcejfzotfeb obi cl kerlsljl`tfvl)
7/27/2019 HCC 2013 SOTA Treatment
22/54
Iexerucf`fb Ljutfbh Clois
Blw lkcejf` kotlrfoj der YO@L Lkcejfzotfeb portf`jls orl koil drek pejyvfbyj
oj`emej myirehlj tmot orl jeoili wftm iexerucf`fb
Clois jloi te juklb e``jusfeb obi fs`mlkfo Iexerucf`fb fs hroiuojjy rljlosli je`ojjy
Il`rlosli jloaohl ed iruh te systlkf` `fr`ujotfeb Jebhlr lxpesurl te tuker `ljjs
*il`rlosli systlkf` sfil lddl`tswftm fb`rlosli rlspebsl
7/27/2019 HCC 2013 SOTA Treatment
23/54
Sliu`fbh Pystlkf` Lxpesurl
Ymfs fs tml rljotfvliruh ifstrfcutfebder stobiori
ortlrfoj`mlketmlropy vs.`ebvlbtfebojYO@L vs. I@
Cloi
Sljotfvl Iruh Ifstrfcutfebs
7/27/2019 HCC 2013 SOTA Treatment
24/54
Wrl`fsfeb T Yrfoj>
I@ Clois vs YO@L
7/27/2019 HCC 2013 SOTA Treatment
25/54
7/27/2019 HCC 2013 SOTA Treatment
26/54
Iexerucf`fb Ljutfbh Clois
Lorjy stuifls smew ot jlost `ekporocjlrlspebsl te `ebvlbtfeboj YO@L
Wessfcfjfty ed jlss oivlrsl lvlbts5 Westlkcejf` sybirekl> pofb, dlvlr, bouslo Jlss iruh lxpesurl te systlkf` `fr`ujotfeb
7/27/2019 HCC 2013 SOTA Treatment
27/54
67Vttrfuk Hjoss Kf`respmlrls
YmlroPpmlrl `ebsfsts ed fbsejucjl 37-07 k hjossspmlrls wftm 67V os ob fbtlhroj `ebstftulbt ed tmlhjoss kotrfx
?77% purl clto lkfttlr
Wmysf`oj mojd-jfdl ed 49.3 m
Ovlrohl tfssul plbltrotfeb robhl ed 3.< kk
7/27/2019 HCC 2013 SOTA Treatment
28/54
Wmosl FF stuiy> B ; ?7= (08 wftm WTY, 8? wftmeut WTY)
Ptrotfdfli cy texf`fty> @mfji-Wuhm s`erl (fb `frrmetf`s), iesl,je`otfeb ed WTY
Klifob iesl> ?09 Hy Wortfoj rlspebsl rotl> 93% (XME), 87% (LOPJ)
Oivlrsl lvlbt rotl mfhmlst fb potflbts wftm kofb WTY obi`frrmesfs
Klifob survfvoj, kofb WTY> 347 ioys Crob`m WTY> 087 ioys Be WTY> 947 ioys
Vttrfuk-67 Soifetmlropy der M@@ Wotflbts Xftm
obi Xftmeut WTY
Aujfa JK, lt oj. Mlpotejehy. 377=198>
7/27/2019 HCC 2013 SOTA Treatment
29/54
YO@L vs V67> lorjy ioto
YO@L (B;33) V67 (B;09) p vojulWortfojrlspebsl
00% 4=%
Pu``lssduj
iewbstohfbh
9?%
7/27/2019 HCC 2013 SOTA Treatment
30/54
67Vttrfuk vs. YO@L
67Vttrfuk iels bet e``juil tml vlssljsot tml ortlrfejor jlvlj Eptfeb der rlplot lkcejf` trlotklbt
Jlss fs`mlkf` iokohl Slspebsl rotls ot jlost sfkfjor Lqufvojlbt sfil lddl`t predfjl
67
Vttrfuk `ob cl usli fb pertoj vlfbtmrekcesfs obi fb kerl lxtlbsfvlifslosl
67Vttrfuk ku`m kerl lxplbsfvl
7/27/2019 HCC 2013 SOTA Treatment
31/54
Yrlotklbt Perodlbfc
Eroj kujtfafbosl fbmfcfter
Fbmfcfts YA fbvejvli fb tuker hrewtm obiobhfehlblsfs
TLHDS-?, TLHDS-3, TLHDS-0, obi WIHDS
fbtro`ljjujor slrfbl/tmrlebfbl afbosls
(l.h. Sod-?, C-Sod ) fbvejvli fb tukeur `ljjprejfdlrotfeb obi tukeur obhfehlblsfs.
Y t t P d fc
7/27/2019 HCC 2013 SOTA Treatment
32/54
Yrlotklbt PerodlbfcKl`mobfsks
Perodlbfc
Y t t P d fc
7/27/2019 HCC 2013 SOTA Treatment
33/54
Yrlotklbt PerodlbfcIuoj torhltfbh
Perodlbfc
Perodlbfc
Perodlbfc
TLHD
LHD/MHD
Purvfvoj
WIHD
Wrejfdlrotfeb
Lbietmljfoj ljjLpftmljfoj ljj
Obhfehlblsfs
Xfjmljk P lt oj. @ob`lr Sls. 3779
Y t t P d fc
7/27/2019 HCC 2013 SOTA Treatment
34/54
Yrlotklbt PerodlbfcSlsujts ed S@Y
Ywe robiekfzli, ieucjl-cjfbi, pjo`lce-
`ebtrejjli, kujtf`lbtrl, pmosl FFF trfojs
?. YmlPMOSW trfoj> Perodlbfc Mlpote`ljjujor @or`fbeko OsslssklbtSobiekfsli Wrete`ej
3. Yml Osfo-Wo`fdf` trfoj
Jjevlt. lt oj. BLNK 377=
@mlbh lt ojJob`lt Eb`ejehy3776
Y t t P d fc
7/27/2019 HCC 2013 SOTA Treatment
35/54
Yrlotklbt PerodlbfcSlsujts ed Wmosl FF stuiy
@mfji O+C, ubtrlotli
977 kh WE CfI
B;?08 WS;3.3% KS;
7/27/2019 HCC 2013 SOTA Treatment
36/54
Yrlotklbt PerodlbfcSlsujts ed PMOSW trfoj
473 pts robiekfzli ?>? (366 obi 070)
Jjevlt. lt oj. BLNK 377=
Perodlbfc
977 kh cfi
Wjo`lce
Ljfhfcfjfty
Oivob`li M@@L@EH 7-3@mfji-Wuhm OBe Wrfer systlkf` tmlropy
Ptrotfdf`otfeb
Ko`res`epf` vos`ujor fbvosfeb(Wertoj Tlfb) obi/er lxtromlpotf` sprloi
L@EH WP
Hlehropmf`rlhfeb
S
O
B
I
7K
F
^
L
b;366
b;070
@e-prfkory lbi pefbts> Evlrojj survfvoj Yfkl te sykptekotf` prehrlssfeb (DMPF=-YPW)
Pl`ebiory lbi pefbt> Yfkl te Wrehrlssfeb
Y t t P d fc
7/27/2019 HCC 2013 SOTA Treatment
37/54
Yrlotklbt PerodlbfcSlsujts ed PMOSW trfoj
Jjevlt. lt oj. BLNK 377=
Wotflbts `moro`tlrfstf`s
@moro`tlrfstf`sPerodlbfc(b-366)
Wjo`lce(b;070)
Ohl (klifob) 4< 44
Kojl =8% =8%Lurepl/BO/etmlr ==/6/0 =8/?7/0
Tfroj (M@T/MCT) 36/?6 38/?=
LYEM/etmlr 34/34 34/36
@mfji-WuhmO/C 6
7/27/2019 HCC 2013 SOTA Treatment
38/54
7
7.3? (?
7/27/2019 HCC 2013 SOTA Treatment
40/54
Yrlotklbt PerodlbfcSlsujts ed Osfo-Wo`fd f` tr foj
Klifob EP 4.
7/27/2019 HCC 2013 SOTA Treatment
41/54
Yrlotklbt PerodlbfcSlsujts ed Osfo-Wo`fd f` tr fojvs . PMOSW
PMOSWJjevlt. lt oj. BLNK 377=
Osfo-Wo`fdf`@mlbh lt ojJob`lt Eb`ejehy3776
EP?7.8 vs. 8.6QMS[ 7.46
4.
7/27/2019 HCC 2013 SOTA Treatment
42/54
Yrlotklbt PerodlbfcSlsujts ed Osfo-Wo`fd f` tr foj
Yexf`fty
@mlbh lt ojJob`lt Eb`ejehy3776
Yrlotklbt Perodlbfc
7/27/2019 HCC 2013 SOTA Treatment
43/54
Yrlotklbt PerodlbfcIruh fbtlro`tfeb
Perodlbfc rlhfklb fs 977 kh Yoalb twf`l iofjy (3 x 377 kh tocjlts)
Xftmeut deei (ot jlost ? mr clderl er 3 mrs odtlr kloj)
Perodlbfc rliu`li cy 08% cy @VW0O9fbiu`lrs (l.h.rfdokpf`fb)
Yrlotklbt Perodlbfc + `mlketmlropy
7/27/2019 HCC 2013 SOTA Treatment
44/54
Yrlotklbt Perodlbfc + `mlketmlropySlsujts ed QIexerucf`fb+ Perodlbfc[ vs. Iexerucf`fb
PMOSWJjevlt. lt oj. BLNK 377=
Osfo-Wo`fdf`@mlbh lt ojJob`lt Eb`ejehy3776
Iexerucf`fb+/-
PerodlbfcOceu-Ojdo lt ojL@@E 3778
EP?7.8 vs. 8.6QMS[ 7.46
4.
7/27/2019 HCC 2013 SOTA Treatment
45/54
Yrlotklbt
Je`ojjyubrlsl`tocjl
Slsl`tocjlwftm heei
jfvlr dub`tfeb(be `frrmesfs)
Y? er Y3
wftm `frrmesfs
Iewb-stohli
Wojjfotfvl YO@Lobi/erPerodlbfcer
suppertfvl `orlEr
`jfbf`oj trfoj
SDOKXOWLF
Wortfojmlpotl`teky Yrobspjobt(prlep JSY)
Lxtromlpotf`sprloi
Pkojj(:0`k)
Jorhl(20`k)
YOCL (+)YOSL
YO@L (+)
@mfji O
M@@
KLJI F dj tf
7/27/2019 HCC 2013 SOTA Treatment
46/54
KLJI Fbdjotfeb
333448484.
survfvoj hlbls
7/27/2019 HCC 2013 SOTA Treatment
49/54
Duturl derM@@
Ifohbesfs&Yrlotklbt
5
Pberrf P. lt oj. N Mlpotejehy
99 (3774) 86==7<
@ Aft obi MHD os Wrlif`ters ed
7/27/2019 HCC 2013 SOTA Treatment
50/54
@-Aft obi MHD os Wrlif`ters edSlspebsl te Perodlbfc
Jjevlt N K lt oj. @jfb @ob`lr Sls 37?31?=>3367-3077
7/27/2019 HCC 2013 SOTA Treatment
51/54
KLY os o Wrehbestf` Do`ter
Klifob EP Wotflbts LvlbtsKLY Ix Jew 6.7 ?0 6KLY Ix Mfhm 0.= ?< ? 3.69 (6 ?.?4-8.90) Jeh Soba> W;7.73
Sfkosso, J, lt oj. Ocstro`t 9774. OP@E 37?3
Wrepertfebe
dWotflbtsPurvfv
fbh
7/27/2019 HCC 2013 SOTA Treatment
52/54
EP fb KLY Ifohbestf` Mfhm
Wrepertfeb
edW
otflbtsPurvfvfbh
Klifob EP Wotflbts Lvlbts
Yfvobtfbfc 8.3 kes 33 ?8Wjo`lce* 0.= kes ?< ? 7.0= (6 7.?=-7.=?) Jeh Soba> W;7.7?
*= KLY Ix Mfhm potflbts `ressli-evlr, < rlkofbli eb eplb-joclj tfvobtfbfc der ot jlost 4wllas (? beb-lvojuocjl ot `ut-edd iotl)Sfkosso, J, lt oj. Ocstro`t 9774.
7/27/2019 HCC 2013 SOTA Treatment
53/54
Kobohlklbt ed Mlpote`ljjujor @or`fbeko Slqufrls oKujtfifs`fpjfbory Oppreo`m
Soifotfeb
Eb`ejehy
Wotmejehy
Eb`ejehy
Soifejehy
Mlpotecfjfory
Purhlry
Mlpotejehy
Ymoba yeu te> tlo`mfbh kl se ku`m obi
7/27/2019 HCC 2013 SOTA Treatment
54/54
Ymoba yeu te> tlo`mfbh kl se ku`m obismorfbh sjfils
H Oceu-Ojdo
@jouil Pfrjfb
Oirfob If Cls`lhjfl Doif Crlftom
@epy ed tmlsl sjfils5 rhfsmGrhfsmkijfvlr`ebsujts.`ek